Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. Dollar Steady Ahead Of U.S. Holiday

Published 11/11/2020, 13:35
Updated 05/03/2019, 13:15

US dollar down slightly in Asia

Overnight the US dollar consolidated on forex markets, with the dollar index almost unchanged at 92.75. Amongst the major currencies, the Japanese yen retraced some of its losses, USD/JPY easing to 105.35 overnight,and dropping further to 105.10 this morning. The sterling continues to outperform, rising 0.80% to 1.3280, after a partial defeat of the Government’s Markets Bill and expectations that a European trade agreement will occur. The large number of Pfizer (NYSE:PFE) vaccines booked by Boris pre-year-end may also be lifting spirits and giving a boost to the pound.

US dollar likely to trade quietly in holiday-thinned market

Although the US holiday today will mute volumes, the dollar is retreating modestly in Asia, with the dollar index falling to 92.65. Commodity currencies are notable outperformers. The AUD/USD has risen 0.35% to 0.7310, while the NZD/USD has jumped 1.0% to 0.6890 after the Reserve Bank of New Zealand left interest rates unchanged this morning at 0.25 per cent. At a time where stock markets are more cautious, currency markets appear content to continue the move into pro-cyclical currencies, after the US election hiccup, spurred on by vaccine recovery hopes.

Asian currencies are also moving higher today, led by the Chinese yuan. USD/CNY has fallen 0.25% to 6.5950 and will be eyeing the week lows at 6.5650. The Korean won, Singapore dollar and Thai baht are also notable outperformers, suggesting that the markets believe that Asia is well placed to outperform, whether vaccines arrive to shorten the Covid-19 recession or not. I can’t disagree.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Overall, I expect the US dollar to continue to gently give ground over this week and next, with any other pharma-companies announcing phase-3 success for a vaccine accelerating that trend. The path may not be linear though, as the US presidential election drama and Trump-tweet risk could cause rapid, if short-term, reversals.

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.